SPONSOR
Skylark Bio Inc.
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Skylark Bio Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including GJB2-mediated Hearing Loss, GJB2 Gene Mutation, DFNB1A.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Skylark Bio Inc.
How many clinical trials has Skylark Bio Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Skylark Bio Inc., of which 1 are actively recruiting participants. These trials cover conditions including GJB2-mediated Hearing Loss, GJB2 Gene Mutation, DFNB1A. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Skylark Bio Inc. research focus on?
Skylark Bio Inc. clinical trials span GJB2-mediated Hearing Loss, GJB2 Gene Mutation, DFNB1A. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Skylark Bio Inc. clinical trial?
To participate in a Skylark Bio Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Skylark Bio Inc. trials with current recruitment status updated daily.
Clinical Trials by Skylark Bio Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology